Skip to main content

Advanced In Vitro and In Vivo Strategies for the Evaluation of Antibody-Drug Conjugates for Oncology

Published Date

Watch Dr. Lenka Sadilkova, Director Non-clinical Projects at Mablink Bioscience - Eli Lilly, present Advanced In Vitro and In Vivo Strategies for the Evaluation of Antibody-Drug Conjugates for Oncology, as part of the virtual summit, "Modeling Human Immunobiology In Vivo: Replacing NHPs with Humanized Mice in Preclinical Antibody Testing", that took place on September 23, 2025.